152 related articles for article (PubMed ID: 27173324)
1. Network spatio-temporal analysis predicts disease stage-related genes and pathways in renal cell carcinoma.
Li1 XH; Yang CZ; Wang J
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173324
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
3. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
4. Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.
Yuan L; Zeng G; Chen L; Wang G; Wang X; Cao X; Lu M; Liu X; Qian G; Xiao Y; Wang X
Int J Biol Sci; 2018; 14(3):266-279. PubMed ID: 29559845
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
Zhai W; Lu H; Dong S; Fang J; Yu Z
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
[TBL] [Abstract][Full Text] [Related]
6. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
[TBL] [Abstract][Full Text] [Related]
7. Screening of feature genes of the renal cell carcinoma with DNA microarray.
Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of the estrogen receptor target genes in renal cell carcinoma.
Liu Z; Lu Y; He Z; Chen L; Lu Y
Mol Med Rep; 2015 Jan; 11(1):75-82. PubMed ID: 25351113
[TBL] [Abstract][Full Text] [Related]
9. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
Wang S; Yu ZH; Chai KQ
Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
[TBL] [Abstract][Full Text] [Related]
10. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
11. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.
S V; Balasubramanian S; Perumal E; Santhakumar K
Cancer Biomark; 2024; 40(1):111-123. PubMed ID: 38427469
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes and pathways in renal cell carcinoma through expression profiling data.
Liu X; Wang J; Sun G
Kidney Blood Press Res; 2015; 40(3):288-97. PubMed ID: 26043775
[TBL] [Abstract][Full Text] [Related]
14. Identifying novel candidate biomarkers of RCC based on WGCNA analysis.
Deng J; Kong W; Mou X; Wang S; Zeng W
Per Med; 2018 Sep; 15(5):381-394. PubMed ID: 30259787
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
[TBL] [Abstract][Full Text] [Related]
16. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
17. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
[TBL] [Abstract][Full Text] [Related]
18. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
[TBL] [Abstract][Full Text] [Related]
19. Micro-RNA378a-3p Induces Apoptosis in Sarcomatoid Renal Cell Carcinoma and Regulates POLR2A and RUNX2 Expression.
Weng WH; Yu KJ; Jhan JW; Pang SN; Chiou YE; Pang ST
Anticancer Res; 2022 Feb; 42(2):811-825. PubMed ID: 35093879
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.
Wang J; Song J; Gao Z; Huo X; Zhang Y; Wang W; Qi J; Zheng S
Oncol Rep; 2017 Mar; 37(3):1736-1746. PubMed ID: 28098899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
